...the discretion of the undisclosed third party. The company said ZolpiMist revenues are not disclosed. Rechon Life Science AB...

...NovaDel granted Rechon an exclusive license to manufacture and commercialize ZolpiMist zolpidem oral spray outside the...
...exclusive license to manufacture and commercialize ZolpiMist zolpidem oral spray outside the U.S. and Canada. Rechon...
...Canada. Terms were not disclosed (see BioCentury, Feb. 14). NovaDel Pharma Inc. (OTCBB:NVDL), Bridgewater, N.J. Rechon Life Science AB...